Literature DB >> 15673189

Amelioration of diabetic nephropathy by dried Rehmanniae Radix (Di Huang) extract.

Takako Yokozawa1, Hyun Young Kim, Noriko Yamabe.   

Abstract

The effects of dried Rehmanniae Radix (Di Huang) extract were investigated using a diabetic nephropathy model: rats given streptozotocin after nephrectomy. The results showed that this crude drug reduced the magnitudes of the increases in glucose, urea nitrogen, 5-hydroxymethylfurfural and thiobarbituric acid (TBA)-reactive substance levels, with the effects being most marked in the high blood glucose group. The renal histopathological lesions, which were conspicuous in rats not given dried Rehmanniae Radix extract, were ameliorated considerably in the high blood glucose group given this extract. It appears that dried Rehmanniae Radix extract may be useful as a therapeutic agent for inhibiting the progression of diabetic nephropathy. On the basis of these results, the possible mechanisms of action of this crude drug are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15673189     DOI: 10.1142/S0192415X04002442

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  16 in total

1.  Huangqi (astragalus) decoction ameliorates diabetic nephropathy via IRS1-PI3K-GLUT signaling pathway.

Authors:  Xia Chen; Hao Wang; Minqian Jiang; Jie Zhao; Chunling Fan; Yunman Wang; Wen Peng
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products.

Authors:  Gui-Hyun Baek; Yong-Suk Jang; Seung-Il Jeong; Jaeho Cha; Myungsoo Joo; Sang-Woo Shin; Ki-Tae Ha; Han-Sol Jeong
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

Review 3.  Chinese medicine for treating diabetic nephropathy.

Authors:  Bin Wang; Lan Lin; Qing Ni; Cheng-lian Su
Journal:  Chin J Integr Med       Date:  2013-03-26       Impact factor: 1.978

Review 4.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

5.  General acteoside of Rehmanniae leaves in the treatment of primary chronic glomerulonephritis: a randomized controlled trial.

Authors:  HongYu Qiu; WenXing Fan; Ping Fu; Chuan Zuo; Ping Feng; Fang Liu; Li Zhou; Feng Chen; Hui Zhong; YaPing Liang; Mei Shi
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-05-16

6.  Hypoglycemic effect of Rehmannie Radix Preparata (Sookjihwang) extract in streptozotocin-induced diabetic rats.

Authors:  Shin-Jyung Kang; Cun Liu Bao; Soojin Park; Ae-Jung Kim
Journal:  Nutr Res Pract       Date:  2010-10-26       Impact factor: 1.926

7.  Clinical Features and Rules of Chinese Herbal Medicine in Diabetic Peripheral Neuropathy Patients.

Authors:  Jindong Zhao; Yan Li; Ling Xin; Min Sun; Chanjuan Yu; Guobin Shi; Taotao Bao; Jian Liu; Yingqun Ni; RuiMin Lu; Yuanyuan Wu; Zhaohui Fang
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-17       Impact factor: 2.629

Review 8.  Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy.

Authors:  Guang-dong Sun; Chao-yuan Li; Wen-peng Cui; Qiao-yan Guo; Chang-qing Dong; Hong-bin Zou; Shu-jun Liu; Wen-peng Dong; Li-ning Miao
Journal:  J Diabetes Res       Date:  2015-11-15       Impact factor: 4.011

9.  The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injury.

Authors:  Sung-Hwa Sohn; HaRyeon Jang; Youngeun Kim; Young Pyo Jang; Seung-Hun Cho; Heejae Jung; Sungki Jung; Hyunsu Bae
Journal:  BMC Complement Altern Med       Date:  2013-07-16       Impact factor: 3.659

10.  Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.

Authors:  Minhee Jang; Min Jung Lee; Jin Moo Lee; Chun-Sik Bae; Sung-Hoon Kim; Jong Hoon Ryu; Ik-Hyun Cho
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.